Fresenius Medical Care AG KGaA Operating Income 2010-2024 | FMS

Fresenius Medical Care AG KGaA annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Fresenius Medical Care AG KGaA operating income for the quarter ending September 30, 2024 was $0.509B, a 44.18% increase year-over-year.
  • Fresenius Medical Care AG KGaA operating income for the twelve months ending September 30, 2024 was $1.694B, a 22.1% increase year-over-year.
  • Fresenius Medical Care AG KGaA annual operating income for 2023 was $1.482B, a 6.95% decline from 2022.
  • Fresenius Medical Care AG KGaA annual operating income for 2022 was $1.593B, a 27.32% decline from 2021.
  • Fresenius Medical Care AG KGaA annual operating income for 2021 was $2.191B, a 16.75% decline from 2020.
Fresenius Medical Care AG KGaA Annual Operating Income
(Millions of US $)
2023 $1,482
2022 $1,593
2021 $2,191
2020 $2,632
2019 $2,542
2018 $3,588
2017 $2,670
2016 $2,638
2015 $2,327
2014 $2,255
2013 $2,230
2012 $2,165
2011 $2,044
2010 $1,924
2009 $1,756
Fresenius Medical Care AG KGaA Quarterly Operating Income
(Millions of US $)
2024-09-30 $509
2024-06-30 $457
2024-03-31 $267
2023-12-31 $460
2023-09-30 $353
2023-06-30 $389
2023-03-31 $280
2022-12-31 $365
2022-09-30 $475
2022-06-30 $362
2022-03-31 $390
2021-12-31 $513
2021-09-30 $595
2021-06-30 $511
2021-03-31 $572
2020-12-31 $559
2020-09-30 $739
2020-06-30 $722
2020-03-31 $612
2019-12-31 $685
2019-09-30 $662
2019-06-30 $586
2019-03-31 $609
2018-12-31 $694
2018-09-30 $612
2018-06-30 $1,671
2018-03-31 $611
2017-12-31 $619
2017-09-30 $715
2017-06-30 $642
2017-03-31 $694
2016-12-31 $786
2016-09-30 $670
2016-06-30 $641
2016-03-31 $540
2015-12-31 $662
2015-09-30 $614
2015-06-30 $547
2015-03-31 $504
2014-12-31 $663
2014-09-30 $590
2014-06-30 $556
2014-03-31 $445
2013-12-31 $659
2013-09-30 $551
2013-06-30 $532
2013-03-31 $487
2012-12-31 $554
2012-09-30 $562
2012-06-30 $560
2012-03-31 $488
2011-12-31 $578
2011-09-30 $528
2011-06-30 $501
2011-03-31 $438
2010-12-31 $542
2010-09-30 $493
2010-06-30 $465
2010-03-31 $424
2009-12-31 $491
2009-09-30 $451
2009-06-30 $418
2009-03-31 $396
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $13.368B $21.053B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.706B 24.73
Intuitive Surgical (ISRG) United States $193.352B 101.09
Alcon (ALC) Switzerland $43.519B 29.12
Edwards Lifesciences (EW) United States $41.599B 26.42
IQVIA Holdings (IQV) United States $36.625B 20.18
IDEXX Laboratories (IDXX) United States $35.273B 41.54
DexCom (DXCM) United States $30.978B 46.65
Waters (WAT) United States $22.985B 33.99
STERIS (STE) Ireland $21.603B 24.87
SONOVA HOLDING (SONVY) Switzerland $20.257B 0.00
Hologic (HOLX) United States $17.928B 19.36
Sysmex ADR (SSMXY) Japan $13.192B 41.37
Globus Medical (GMED) United States $11.424B 28.93
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.192B 44.48
Teleflex (TFX) United States $9.024B 14.39
Glaukos (GKOS) United States $7.669B 0.00
PROCEPT BioRobotics (PRCT) United States $5.015B 0.00
Integer Holdings (ITGR) United States $4.655B 26.38
Veracyte (VCYT) United States $3.419B 102.61
Inari Medical (NARI) United States $3.051B 0.00
TransMedics (TMDX) United States $2.857B 90.57
LivaNova (LIVN) United Kingdom $2.839B 16.39
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.209B 19.86
Tandem Diabetes Care (TNDM) United States $2.135B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.848B 0.00
Alphatec Holdings (ATEC) United States $1.448B 0.00
Pulse Biosciences (PLSE) United States $1.284B 0.00
Artivion (AORT) United States $1.242B 82.28
OPKO Health (OPK) United States $1.044B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.901B 15.31
Paragon 28 (FNA) United States $0.864B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.738B 0.00
IRadimed (IRMD) United States $0.682B 36.87
Mesa Laboratories (MLAB) United States $0.660B 15.55
AxoGen (AXGN) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.561B 0.00
Treace Medical Concepts (TMCI) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Semler Scientific (SMLR) United States $0.503B 29.61
Tactile Systems Technology (TCMD) United States $0.446B 24.14
Delcath Systems (DCTH) United States $0.404B 0.00
CVRx (CVRX) United States $0.377B 0.00
ClearPoint Neuro (CLPT) United States $0.338B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.241B 0.00
Accuray (ARAY) United States $0.216B 0.00
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.160B 0.00
Sensus Healthcare (SRTS) United States $0.140B 15.02
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.100B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.088B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Vicarious Surgical (RBOT) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
Lucid Diagnostics (LUCD) United States $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00